171 related articles for article (PubMed ID: 29531746)
21. Malignant pleural mesothelioma.
Kindler HL
Curr Treat Options Oncol; 2000 Oct; 1(4):313-26. PubMed ID: 12057157
[TBL] [Abstract][Full Text] [Related]
22. Pleural mesothelioma. (A case report).
EL-WARRAKI S
J Egypt Med Assoc; 1959; 42():627-9. PubMed ID: 13832472
[No Abstract] [Full Text] [Related]
23. The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
Novello S; Pinto C; Torri V; Porcu L; Di Maio M; Tiseo M; Ceresoli G; Magnani C; Silvestri S; Veltri A; Papotti M; Rossi G; Ricardi U; Trodella L; Rea F; Facciolo F; Granieri A; Zagonel V; Scagliotti G
Crit Rev Oncol Hematol; 2016 Aug; 104():9-20. PubMed ID: 27286698
[TBL] [Abstract][Full Text] [Related]
24. A Narrative Review-Management of Malignant Pleural Effusion Related to Malignant Pleural Mesothelioma.
Qureshi M; Thapa B; Muruganandan S
Heart Lung Circ; 2023 May; 32(5):587-595. PubMed ID: 36925448
[TBL] [Abstract][Full Text] [Related]
25. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Popat S; Baas P; Faivre-Finn C; Girard N; Nicholson AG; Nowak AK; Opitz I; Scherpereel A; Reck M;
Ann Oncol; 2022 Feb; 33(2):129-142. PubMed ID: 34861373
[No Abstract] [Full Text] [Related]
26. The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma.
Lovrenski A; Panjković M; Tegeltija D; Latinović LT; Krcedinac J
Med Pregl; 2012; 65(1-2):5-8. PubMed ID: 22452231
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-5-producing malignant pleural mesothelioma with eosinophilic pleural effusion.
Takeuchi E; Takahashi N; Morizumi S; Tamiya H; Matsuoka H; Kuroda N; Yorita K
Thorac Cancer; 2020 Oct; 11(10):3043-3046. PubMed ID: 32894005
[TBL] [Abstract][Full Text] [Related]
28. Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation.
Mattson K; Holsti LR; Tammilehto L; Maasilta P; Pyrhönen S; Mäntylä M; Kajanti M; Salminen US; Rautonen J; Kivisaari L
Int J Radiat Oncol Biol Phys; 1992; 24(4):643-50. PubMed ID: 1429086
[TBL] [Abstract][Full Text] [Related]
29. [Video-assisted thoracoscopic surgery in diagnostic and treatment of non-operable malignant pleural mesothelioma].
Murdzhev K; Uchikov A; Iankulov A; Paskalev G
Khirurgiia (Sofiia); 2007; (4):23-6. PubMed ID: 18443531
[TBL] [Abstract][Full Text] [Related]
30. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
[TBL] [Abstract][Full Text] [Related]
31. [Malignant diffuse pleural mesothelioma: a comparison between computed tomography and the conventional chest x-ray].
Bohndorf K; Sepehr H; Calavreszos A; Koschel G; Hain E
Digitale Bilddiagn; 1985 Mar; 5(1):10-5. PubMed ID: 3987190
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline].
Süß C; Kölbl O
Strahlenther Onkol; 2018 Oct; 194(10):953-957. PubMed ID: 30187114
[No Abstract] [Full Text] [Related]
33. Malignant pleural mesothelioma: the standard of care and challenges for future management.
van Meerbeeck JP; Scherpereel A; Surmont VF; Baas P
Crit Rev Oncol Hematol; 2011 May; 78(2):92-111. PubMed ID: 20466560
[TBL] [Abstract][Full Text] [Related]
34. Synchronous pulmonary carcinoma and pleural diffuse malignant mesothelioma.
Allen TC; Moran C
Arch Pathol Lab Med; 2006 May; 130(5):721-4. PubMed ID: 16683892
[TBL] [Abstract][Full Text] [Related]
35. Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.
Alley EW; Lopez J; Santoro A; Morosky A; Saraf S; Piperdi B; van Brummelen E
Lancet Oncol; 2017 May; 18(5):623-630. PubMed ID: 28291584
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma.
Moro J; Sobrero S; Cartia CF; Ceraolo S; Rapanà R; Vaisitti F; Ganio S; Mellone F; Rudella S; Scopis F; La Paglia D; Cacciatore CC; Ruffini E; Leo F
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553016
[TBL] [Abstract][Full Text] [Related]
37. Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes.
Hoang CD; Zhang X; Scott PD; Guillaume TJ; Maddaus MA; Yee D; Kratzke RA
Cancer Res; 2004 Oct; 64(20):7479-85. PubMed ID: 15492273
[TBL] [Abstract][Full Text] [Related]
38. Clinical course of human epithelial-type malignant pleural mesothelioma replicated in an orthotopic-transplant nude mouse model.
Colt HG; Astoul P; Wang X; Yi ES; Boutin C; Hoffman RM
Anticancer Res; 1996; 16(2):633-9. PubMed ID: 8687108
[TBL] [Abstract][Full Text] [Related]
39. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining.
Kwee WS; Veldhuizen RW; Golding RP; Mullink H; Stam J; Donner R; Boon ME
Virchows Arch A Pathol Anat Histol; 1982; 397(3):287-99. PubMed ID: 6186071
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.
Loveland P; Christie M; Hammerschlag G; Irving L; Steinfort D
Intern Med J; 2018 Nov; 48(11):1318-1324. PubMed ID: 29869427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
